Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Aisling Capital Management Lp > Profile

Instuitional Investor - Aisling Capital Management Lp

Fund Profile
Filing Period:
Fund Name: Aisling Capital Management Lp
Portfolio Value $288,452,198
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Bridgebio Pharma Inc.
 BBIO 6,068,125 $209,775,081 72.72%
2.
Verona Pharma Plc
 VRNA 615,352 $39,068,698 13.54%
3.
Syndax Pharmaceuticals Inc
 SNDX 1,025,000 $12,587,000 4.36%
4.
Bicara Therapeutics Inc. (Bcax)
 568,919 $7,413,015 2.57%
5.
Monte Rosa Therapeutics Inc.
 GLUE 1,472,331 $6,831,616 2.37%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)